Open access publisher BioMed Central, UK, has announced that its journal Cell Division has been accepted for tracking by Thomson Reuters. The journal will get its first official Impact Factor in June 2011.
Launched in 2006, Cell Division publishes high quality research on all aspects of the cell-cycle. The journal seeks to bridge the gap between models of cell cycle regulation, development and cancer biology. This forum is driven by specialised and timely research articles, reviews and commentaries focused on this fast moving field. The journal is projected as an invaluable tool for cell-cycle biologists. The predicted Impact Factor for this journal, based upon citations to the journal over the past three years, is 3.37.
Recent research published in the journal ranges from studies of yeast mutants, specifically defective in DNA replication initiation, to genetic regulation of the cell cycle in human cancer cells. Last month saw the publication of an already highly accessed review in the journal that dissects new discoveries in the Jab1 signaling pathway in cell cycle control and cancer.
Search for more Biology related STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
